Advertisement
Screener

NATERA, INC. (NTRA) Contract with Customer, Liability, Change in Timeframe, Performance Obligation Satisfied, Revenue Recognized

3.2 / 5 stars · 67/106 Roast Me

NATERA, INC. Contract with Customer, Liability, Change in Timeframe, Performance Obligation Satisfied, Revenue Recognized

NATERA, INC. (NTRA) reported Contract with Customer, Liability, Change in Timeframe, Performance Obligation Satisfied, Revenue Recognized of -$17.05 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.

Financial Statements › Income Statement › Other Income

us-gaap:ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized · last filed 2026-08-07

  • NATERA, INC. contract with customer, liability, change in timeframe, performance obligation satisfied, revenue recognized for the quarter ending 2026-03-31 was -$5.23M.
  • NATERA, INC. contract with customer, liability, change in timeframe, performance obligation satisfied, revenue recognized for the quarter ending 2025-03-31 was -$75.00K.
  • NATERA, INC. contract with customer, liability, change in timeframe, performance obligation satisfied, revenue recognized for the quarter ending 2024-03-31 was -$100.00K.
  • NATERA, INC. contract with customer, liability, change in timeframe, performance obligation satisfied, revenue recognized for the quarter ending 2023-03-31 was -$800.00K.
  • NATERA, INC. contract with customer, liability, change in timeframe, performance obligation satisfied, revenue recognized for fiscal 2025 was -$25.88M.
  • NATERA, INC. contract with customer, liability, change in timeframe, performance obligation satisfied, revenue recognized for fiscal 2024 was -$20.89M.
  • NATERA, INC. contract with customer, liability, change in timeframe, performance obligation satisfied, revenue recognized for fiscal 2023 was -$19.52M.
  • NATERA, INC. contract with customer, liability, change in timeframe, performance obligation satisfied, revenue recognized for fiscal 2022 was -$17.80M.
Period endContract with Customer, Liability, Change in Timeframe, Performance Obligation Satisfied, Revenue Recognized 3 monthContract with Customer, Liability, Change in Timeframe, Performance Obligation Satisfied, Revenue Recognized 6 monthContract with Customer, Liability, Change in Timeframe, Performance Obligation Satisfied, Revenue Recognized 9 monthContract with Customer, Liability, Change in Timeframe, Performance Obligation Satisfied, Revenue Recognized 12 month
2026-06-30-$17.05M
10-Q · filed 2026-08-07
2026-03-31-$5.23M
10-Q · filed 2026-05-08
2025-12-31-$25.88M
10-K · filed 2026-02-27
2025-09-30-$12.79M
10-Q · filed 2025-11-07
2025-06-30-$4.00M
10-Q · filed 2026-08-07
2025-03-31-$75.00K
10-Q · filed 2026-05-08
2024-12-31-$20.89M
10-K · filed 2026-02-27
2024-09-30-$12.80M
10-Q · filed 2025-11-07
2024-06-30-$4.14M
10-Q · filed 2025-08-08
2024-03-31-$100.00K
10-Q · filed 2025-05-09
2023-12-31-$19.52M
10-K · filed 2025-02-28
2023-09-30-$9.68M
10-Q · filed 2024-11-12
2023-06-30-$3.51M
10-Q · filed 2024-08-09
2023-03-31-$800.00K
10-Q · filed 2024-05-10
2022-12-31-$17.80M
10-K · filed 2024-02-29
2022-09-30-$12.44M
10-Q · filed 2023-11-09
2022-06-30-$1.21M
10-Q · filed 2023-08-04
2022-03-31-$884.00K
10-Q · filed 2023-05-10
2021-12-31-$4.26M
10-K · filed 2023-03-01
2021-09-30-$2.40M
10-Q · filed 2022-11-09
2021-06-30-$1.36M
10-Q · filed 2022-08-05
2021-03-31-$783.00K
10-Q · filed 2022-05-06
2020-12-31-$1.25M
10-K · filed 2021-02-26
2020-09-30-$957.00K
10-Q · filed 2020-11-06
2020-06-30-$702.00K
10-Q · filed 2020-08-07
2020-03-31-$87.00K
10-Q · filed 2020-05-08
2019-12-31-$23.21M
10-K · filed 2020-03-02
2019-09-30-$18.94M
10-Q · filed 2019-11-08
2019-06-30-$9.30M
10-Q · filed 2019-08-09
2019-03-31-$1.49M
10-Q · filed 2019-05-10
2018-12-31$10.20M
10-K · filed 2019-03-15
2018-09-30-$796.00K
10-Q · filed 2018-11-09
2018-06-30-$363.00K
10-Q · filed 2018-08-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
QUEST DIAGNOSTICS INC (DGX)United States$26.096B22.09
LABCORP HOLDINGS INC. (LH)United States$25.060B22.60
Guardant Health, Inc. (GH)United States$23.675B-12.65
Caris Life Sciences, Inc. (CAI)United States$9.119B47.87
RadNet, Inc. (RDNT)United States$5.611B-229.65
GRAIL, Inc. (GRAL)United States$5.591B-7.78
VERACYTE, INC. (VCYT)United States$3.904B41.21
Celcuity Inc. (CELC)United States$3.887B-22.62
CareDx, Inc. (CDNA)United States$3.174B13.21
Fortrea Holdings Inc. (FTRE)United States$1.903B-19.43